Business & Finance
Immune system-focused biopharmaceutical company listed on OTC Bulletin Board
Published in AIDS Weekly, January 23rd, 2006
IMNR's HIV products are based on its patented whole inactivated virus technology, co-invented by company founder Dr. Jonas Salk to stimulate HIV immune responses. Remune, currently in phase 2 clinical trials, is being developed as a first-line treatment for people with early-stage HIV.
IMNR also developing an immune-based therapy for MS, NeuroVax, which is currently in phase 2 clinical trials.
The OTC Bulletin Board (OTCBB) is a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-23)
More Articles from AIDS Weekly
- Genetics & Genomics
South African GB virus C genotypes inhibit HIV replication - HIV/AIDS Drug Adherence
Obtaining refills via pill organizers dispensed by pharmacist improves HAART adherence - HIV/AIDS Drug Interaction
Didenosine EC AUC is increased when dosed along with tenofovir DF - HIV/AIDS Pathogenesis
HIV-1 VPR protects against lethal superantigen challenge while maintaining T cell levels - HIV/AIDS Pathogenesis
Tat-specific CD8 cells suppress SIV replication more effectively than Gag-specific cells - Adolescent Health
Study supports goal of abstinence but is critical of abstinence-only programs - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
